The British government is set to launch a pilot program to explore the use of new weekly weight-loss shots, such as Novo Nordisk A/S's (NYSE: NVO) Wegovy (semaglutide), for obese...
Ozempic, a medication used to treat Type 2 diabetes, has gone viral as a weight loss drug. Does Medicare pay for it? Here's when it does and doesn't.
Novo Nordisk NVO has entered into exclusive negotiations to acquire a controlling stake in French medical device maker Biocorp in a deal that values Biocorp at 154.4 million euros,...
Teens and older adults at risk, say doctors and researchers, as Novo Nordisk’s Wegovy and Ozempic are hyped heavily online.
Dark sides of weight-loss-drug craze: risky knockoffs, eating disorders and more
By Saeed Azhar and Shreyashi Sanyal NEW YORK (Reuters) - Wall Street finished mixed on Monday, with the Nasdaq helped by gains in Alphabet (NASDAQ:GOOGL) and Meta Platforms, while...
Novo Nordisk A/S (NYSE: NVO) announced headline results from OASIS 1 Phase 3a trial in the global OASIS program. OASIS 1 is a 68-week, efficacy, and safety trial comparing...